Literature DB >> 2304736

Prazosin-induced stress incontinence.

L L Wall1, W A Addison.   

Abstract

A case of genuine stress incontinence due to prazosin, a common antihypertensive drug, is presented. Prazosin exerts its antihypertensive effects through vasodilatation caused by selective blockade of postsynaptic alpha-1 adrenergic receptors. As an alpha-blocker, it also exerts a significant relaxant effect on the bladder neck and urethra. The patient's clinical course is described and correlated with initial urodynamic studies while on prazosin and subsequent studies while taking verapamil. Her incontinence resolved with the change of medication. The restoration of continence was accompanied by a substantial rise in maximum urethral pressure, maximum urethral closure pressure, and functional urethral length. Patients who present with stress incontinence while taking prazosin should change their antihypertensive medication before considering surgery, because their incontinence may resolve spontaneously with a change in drug therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304736

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  An algorithm for the management of urinary stress incontinence.

Authors:  J L Cornella; J F Magrina
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Medical conditions, medications, and urinary incontinence. Analysis of a population-based survey.

Authors:  Murray M Finkelstein
Journal:  Can Fam Physician       Date:  2002-01       Impact factor: 3.275

Review 3.  [The medication-induced dysfunction of the urinary bladder].

Authors:  T Schneider; H Rübben; M C Michel
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

Review 4.  Drug-induced urinary incontinence.

Authors:  Peter Tsakiris; Matthias Oelke; Martin C Michel
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Sacral nerve stimulation to treat nonobstructive urinary retention in women.

Authors:  Craig V Comiter
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

Review 6.  Adverse effects of alpha 1-adrenergic blocking drugs.

Authors:  S G Carruthers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.